Effect of hepatogomax on serum alkaline phosphatase, bilirubin, gamma-glutamyl transferase levels in Sprague Dawley rats cirrhosis

Elfrida Sianturi -  Departemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, Semarang, Indonesia
Hery Djagat Purnomo -  Fakultas Kedokteran, Universitas Diponegoro, Semarang, Indonesia
Adriyan Pramono* -  Departemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, Semarang, Indonesia
Endang Mahati -  Departemen Farmakologi dan Terapi, Fakultas Kedokteran, Universitas Diponegoro, Semarang, Indonesia
Etika R. Noer -  Departemen Ilmu Gizi, Fakultas Kedokteran, Universitas Diponegoro, Semarang, Indonesia
DOI : 10.30867/action.v8i2.969

Supp. File(s): common.other common.other common.other common.other

Cirrhosis is the final stage of all chronic liver diseases. Complications that occur are malnutrition. Administration of Hepatogomax as an enteral formula with adequate nutrients, specifically Branched-Chain Amino Acids (BCAA) and Medium-chain Triglyceride (MCT), can reduce serum ALP, bilirubin, and GG levels. This study aimed to determine the effect of hepatogomax in different doses on serum ALP, bilirubin, and GG levels. The study used the True Experimental post-test group design. Twenty-four male rats were divided into control group K normal and K(-) cirrhotic, treatment groups P1 and P2, given TAA and hepatogomax induction, respectively, at doses of 4,87 g/200gBW/day and 14,6 g/200gBW/day. Intervention for 28 days at the PAU Laboratory, Gadjah Mada University, February 2022 to April 2022. Statistical analysis used the Kruskal Wallis and Mann Whitney Post Hoc tests. The data is the result of examining serum levels after the intervention. The results showed significant differences in ALP, bilirubin, and GGT (p<0,05) in the group of rats induced by TAA intervention with hepatogomax compared to those not given hepatogomax. There was no significant difference in the decrease in serum ALP levels between the K normal (p<0,05) and P2 (p>0,05) groups. Giving hepatogomax at a dose of 14,6 g/200BB/day reduced serum ALP, bilirubin, and GG levels. In conclusion, Hepatogomax decreased ALP, bilirubin, and GGT serum levels in rats with cirrhosis. The most significant decrease in serum ALP, bilirubin, and GGT levels was observed at the P2 dose.  

Supplement Files

Keywords : ALP, bilirubin, cirrhosis, Hepatogomax, GGT, malnutrition

  1. Abdelbasset, W. K., Nambi, G., Elsayed, S. H., Moawd, S. A., Ibrahim, A. A., Verma, A., Tantawy, S. A., Kamel, D. M., Saleh, A. K., Aldhafian, O. R., & Nwihadh, N. Bin. (2021). Prevalence and nonpharmacological interventions for sarcopenia among cirrhotic patients. Disease Markers, 2021. https://doi.org/10.1155/2021/8866093
  2. Al-Attar, A. M., & Al-Rethea, H. A. (2017). Chemoprotective effect of omega-3 fatty acids on thioacetamide induced hepatic fibrosis in male rats. Saudi Journal of Biological Sciences, 24(4), 956–965. https://doi.org/10.1016/j.sjbs.2016.01.029
  3. Choirun Nissa, Ayu Rahadiyanti, Fillah Fithra Dieny, D. Y. F. (2019). Modul Praktikum Enteral dan Parenteral. In Penerbit K-Media Yogyakarta,2019 (Vol. 3).
  4. Eguchi, A., Iwasa, M., Tamai, Y., Tempaku, M., Takamatsu, S., Miyoshi, E., Hasegawa, H., Kobayashi, Y., & Takei, Y. (2021). Branched-chain amino acids protect the liver from cirrhotic injury via suppression of activation of lipopolysaccharide-binding protein , toll- like receptor 4 , and signal transducer and activator of transcription 3 , as well as Enterococcus faecalis tran. Nutrition, 86, 111194. https://doi.org/10.1016/j.nut.2021.111194
  5. Esin, K., Bingöl, F. N., & Akbulut, G. (2017). Kronik karaciğer hastalıklarında tıbbi beslenme tedavisi. Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 6(1), 156–170.
  6. Hammad, A., Kaido, T., Aliyev, V., Mandato, C., & Uemoto, S. (2017). Nutritional therapy in liver transplantation. Nutrients, 9(10), 1–25. https://doi.org/10.3390/nu9101126
  7. Iwasa, M., Kobayashi, Y., Mifuji-Moroka, R., Hara, N., Miyachi, H., Sugimoto, R., Tanaka, H., Fujita, N., Gabazza, E. C., & Takei, Y. (2013). Branched-Chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosis. PLoS ONE, 8(7). https://doi.org/10.1371/journal.pone.0070309
  8. Park, J. G., Tak, W. Y., Park, S. Y., Kweon, Y. O., Chung, W. J., Jang, B. K., Bae, S. H., Lee, H. J., Jang, J. Y., Suk, K. T., Oh, M. J., Heo, J., Woo, H. Y., Jang, S. Y., Lee, Y. R., Lee, J. S., Kim, D. Y., Kim, S. H., Suh, J. I., … Lee, W. K. (2020). Effects of branched-chain amino acid (BCAA) supplementation on the progression of advanced liver disease: a Korean nationwide, multicenter, prospective, observational, cohort study. Nutrients, 12(5), 1429. https://doi.org/10.3390/nu12051429
  9. Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019). ESPEN guideline on clinical nutrition in liver disease. Clinical Nutrition, 38(2), 485–521. https://doi.org/10.1016/j.clnu.2018.12.022
  10. Purba, B. T., & Sinurat, L. R. (2018). Peningkatan Status Gizi Pada Pasien Sirosis Hepatis Melalui Regimen Nutrisi Di Rsu Sari Mutiara Medan. Idea Nursing Journal, 9(2), 1–6. https://doi.org/10.52199/inj.v9i2.12559
  11. Ra, S. H., Shin, R. H., Ri, H. C., Ri, J. H., Ri, H. C., & Ri, A. J. (2019). Effect of lesimarin against thioacetamide-induced liver cirrhosis in rat. Brazilian Journal of Pharmaceutical Sciences, 55, 1–9. https://doi.org/10.1590/s2175-97902019000217821
  12. Rahmadanti, T. S., Candra, A., & Nissa, C. (2020). Pengembangan formula enteral hepatogomax untuk penyakit hati berbasis tepung kedelai dan tepung susu kambing. Jurnal Gizi Indonesia (The Indonesian Journal of Nutrition), 9(1), 1–10. https://doi.org/10.14710/jgi.9.1.1-10
  13. Rashati, D., & Eryani, M. C. (2019). Gambaran asuhan gizi pada pasien sirosis hepatis dengan hematemesis melena di Rumah Sakit Umum Daerah DR. Saiful Anwar Malang. Jurnal Informasi Kesehatan Indonesia, 5(2), 58–64.
  14. Rosida, A. (2016). Pemeriksaan laboratorium penyakit hati. Berkala Kedokteran, 12(1), 123. https://doi.org/10.20527/jbk.v12i1.364
  15. Ruiz-Margáin, A., Macías-Rodríguez, R. U., Ríos-Torres, S. L., Román-Calleja, B. M., Méndez-Guerrero, O., Rodríguez-Córdova, P., & Torre, A. (2018). Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis. Revista de Gastroenterologia de Mexico, 83(1), 9–15. https://doi.org/10.1016/j.rgmx.2017.02.005
  16. Setianingrum, A., & Padaga, M. C. (2019). Antioxidant activity of goat milk yogurt casein on dioxin intoxicated rat liver function. Veterinary Biomedical and Clinical Journal, 1(1), 26–32. https://doi.org/10.21776/ub.vetbioclinj.2019.001.01.4
  17. Shashidhar, K. N., & Nallagangula, K. S. (2019). Pros and Cons of Existing Biomarkers for Cirrhosis of Liver. Acta Sci. Med. Sci, 3(6), 63–72. http://www.medicalworld.co.in/2017/08/chronic-liver-failure.html
  18. Silva, M., Gomes, S., Peixoto, A., Torres-Ramalho, P., Cardoso, H., Azevedo, R., Cunha, C., & Macedo, G. (2015). Nutrition in chronic liver disease. GE Portuguese Journal of Gastroenterology, 22(6), 268–276. https://doi.org/10.1016/j.jpge.2015.06.004
  19. Tajiri, K., & Shimizu, Y. (2018). Branched-chain amino acids in liver diseases. Translational Gastroenterology and Hepatology, 3(July), 1–11. https://doi.org/10.21037/tgh.2018.07.06
  20. Traub, J., Reiss, L., Aliwa, B., & Stadlbauer, V. (2021). Malnutrition in patients with liver cirrhosis. Nutrients, 13(2), 1–19. https://doi.org/10.3390/nu13020540
  21. Uchendu, I. K., Agu, C. E., Orji, O. C., Chekwube, E. B., Chukwu, J., Bitrus, N. E., Nwosu, T. F., & Apara, O. P. (2017). Effect of soy (Glycine max) against alcohol-induced biochemical alteration in liver of male albino rat. Der Pharma Chemica, 9(16), 115–1198.
  22. Yusra, Y., Alvonico, T., & Adiyanti, S. S. (2020). Alkaline phosphatase, bilirubin, and gamma-glutamyl transferase profiles as supporting diagnosis in liver cirrhosis based on aspartate aminotransferase to platelet ratio index score. EJournal Kedokteran Indonesia, 8(1), 36–39. https://doi.org/10.23886/ejki.8.10923.
  23. Zakaria, Z. A., Rofiee, M. S., Somchit, M. N., Zuraini, A., Sulaiman, M. R., Teh, L. K., Salleh, M. Z., & Long, K. (2011). Hepatoprotective activity of dried- and fermented-processed virgin coconut oil. Evidence-Based Complementary and Alternative Medicine, 2011, 8. https://doi.org/10.1155/2011/142739

Open Access Copyright (c) 2023 Elfrida Sianturi, Hery Djagat Purnomo, Adriyan Pramono, Endang Mahati, Etika R. Noer
Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

AcTion: Aceh Nutrition Journal
Published by: Department of Nutrition at the Health Polytechnic of Aceh, Ministry of Health.
Soekarno-Hatta Street, No. 168. Health Polytechnic of Aceh, Aceh Besar, 23352. Telp/Fax: 0651 46126 / 0651 46121.
Website: https://gizipoltekkesaceh.ac.id/
E-mail: [email protected]

e-issn: 2548-5741, p-issn: 2527-3310

All content is licensed under a: Creative Commons Attribution ShareAlike 4.0 International License

View My Stats

Get a feed by atom here, RRS2 here and OAI Links here